{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:32:23Z","timestamp":1754152343576,"version":"3.41.2"},"reference-count":0,"publisher":"Canadian Society of Healthcare-Systems Pharmacy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Hosp Pharm"],"abstract":"<jats:p>Background: The choice of inhaler device type can play a crucial role in managing asthma and chronic obstructive pulmonary disease (COPD). With various devices available, differences in choice and application may lead to confusion for both prescribers and patients. Furthermore, improper use of a device may lead to suboptimal or inadequate treatment.\nObjectives: The primary objective was to identify factors that prescribers consider when selecting an inhaler device for a patient. The secondary objective was to evaluate the rankings of these factors, including identification of which factors had greater importance and frequency for prescribers\u2019 choice of inhaler device for patients.\nMethods: A 10-question online survey was developed and distributed in late 2021 to prescribers (physicians, nurse practitioners, and pharmacists) in western Canada in an outpatient setting. Prescribers were asked to use their own words to describe the factors they considered important and were then asked to rank the stated factors in order of importance for 2 scenarios: an 83-year-old woman with COPD and a 21-year-old man with asthma. The results were examined qualitatively and quantitatively. Recurring themes were identified, and each response was categorized on the basis of its corresponding theme.\nResults: In all, 82 respondents completed the survey (yielding a total of 164 responses across the 2 scenarios). Overall, prescriber experience (84\/164, 51%), cost (84\/164, 51%), patient ease of use (59\/164, 36%), and other patient considerations (49\/164, 30%) were the factors most frequently mentioned. The prescriber\u2019s experience was most often mentioned as a factor for scenario 1 (COPD), whereas cost was most often mentioned for scenario 2 (asthma). In both scenarios, prescriber experience was the highest-ranked factor.\nConclusions: When determining the appropriate type of inhaler device, respondents frequently prioritized their own experience, as well as cost and ease of use. However, many respondents ranked prescriber experience higher than all other factors.\nKeywords: inhaler devices, asthma, chronic obstructive pulmonary disease, prescriber decision-making, patient-centred care\nR\u00c9SUM\u00c9\nContexte : Le choix du type d\u2019inhalateur peut jouer un r\u00f4le crucial dans la gestion de l\u2019asthme et de la maladie pulmonaire obstructive chronique (MPOC). \u00c9tant donn\u00e9 la diversit\u00e9 des dispositifs disponibles, les diff\u00e9rences de choix et d\u2019application peuvent pr\u00eater \u00e0 confusion tant pour les prescripteurs que pour les patients. De plus, la mauvaise utilisation d\u2019un appareil peut conduire \u00e0 un traitement sous-optimal ou inad\u00e9quat.\nObjectifs : L\u2019objectif principal consistait \u00e0 identifier les facteurs pris en compte par les prescripteurs lors de la s\u00e9lection de l\u2019inhalateur pour un patient. L\u2019objectif secondaire consistait \u00e0 \u00e9valuer le classement de ces facteurs, notamment l\u2019identification des facteurs les plus importants et des inhalateurs les plus fr\u00e9quemment choisis par les prescripteurs.\nM\u00e9thodes : Un sondage en ligne de 10 questions a \u00e9t\u00e9 pr\u00e9par\u00e9 et distribu\u00e9 fin 2021 aux prescripteurs (m\u00e9decins, infirmi\u00e8res praticiennes et pharmaciens) de l\u2019ouest du Canada en milieu ambulatoire. Les prescripteurs devaient, dans leurs propres mots, d\u00e9crire les facteurs qui leur semblaient importants avant de les classer par ordre d\u2019importance dans le cadre de deux sc\u00e9narios : une femme de 83 ans atteinte de MPOC et un homme de 21 ans avec de l\u2019asthme. Les r\u00e9sultats ont fait l\u2019objet d\u2019un examen qualitatif et quantitatif. Des th\u00e8mes r\u00e9currents ont \u00e9t\u00e9 identifi\u00e9s et chaque r\u00e9ponse a \u00e9t\u00e9 cat\u00e9goris\u00e9e en fonction du th\u00e8me correspondant.\nR\u00e9sultats : Au total, 82 r\u00e9pondants ont r\u00e9pondu au sondage (total de 164 r\u00e9ponses dans les 2 sc\u00e9narios). Dans l\u2019ensemble, l\u2019exp\u00e9rience du prescripteur (84\/164, 51 %), le co\u00fbt (84\/164, 51 %), la facilit\u00e9 d\u2019utilisation pour le patient (59\/164, 36 %) et d\u2019autres consid\u00e9rations en rapport avec le patient (49\/164, 30 %) \u00e9taient les facteurs d\u00e9terminants les plus fr\u00e9quemment mentionn\u00e9s. Pour le sc\u00e9nario 1 (MPOC), l\u2019exp\u00e9rience du prescripteur \u00e9tait le facteur le plus souvent mentionn\u00e9, alors que le co\u00fbt l\u2019\u00e9tait pour le sc\u00e9nario 2 (asthme). Dans les deux sc\u00e9narios, l\u2019exp\u00e9rience du prescripteur \u00e9tait le facteur le plus important.\nConclusions : Lors de la d\u00e9termination du type d\u2019inhalateur appropri\u00e9, les r\u00e9pondants ont souvent donn\u00e9 la priorit\u00e9 \u00e0 leur exp\u00e9rience personnelle, ainsi qu\u2019au co\u00fbt et \u00e0 la facilit\u00e9 d\u2019utilisation. Cependant, de nombreux r\u00e9pondants ont accord\u00e9 une note plus \u00e9lev\u00e9e \u00e0 l\u2019exp\u00e9rience du prescripteur qu\u2019\u00e0 d\u2019autres facteurs.\nMots-cl\u00e9s : inhalateurs, asthme, maladie pulmonaire obstructive chronique, prise de d\u00e9cision du prescripteur, soins centr\u00e9s sur le patient<\/jats:p>","DOI":"10.4212\/cjhp.3507","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T13:57:55Z","timestamp":1712757475000},"source":"Crossref","is-referenced-by-count":0,"title":["How Patient-Centred Are Inhaler Device Choices? A Survey of Canadian Prescribers"],"prefix":"10.4212","volume":"77","author":[{"given":"Ingrid","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Korownyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kolber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Tejani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2732","published-online":{"date-parts":[[2024,4,10]]},"container-title":["Canadian Journal of Hospital Pharmacy"],"original-title":[],"link":[{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3507\/5267","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3507\/5278","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3507\/5267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:15:18Z","timestamp":1753118118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/view\/3507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,12]]}},"URL":"https:\/\/doi.org\/10.4212\/cjhp.3507","relation":{},"ISSN":["1920-2903","0008-4123"],"issn-type":[{"type":"electronic","value":"1920-2903"},{"type":"print","value":"0008-4123"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"article-number":"e3507"}}